| Members |
targetComponentId |
| Coal tar extract 2% shampoo |
Product containing precisely coal tar 20 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) |
| Coal tar ointment |
Coal tar |
| Coal tar topical solution |
Coal tar |
| Cocaine - non-pharmaceutical |
Cocaine (substance) |
| Cocaine - pharmaceutical |
Cocaine (substance) |
| Cocaine 10% nasal drops |
Cocaine 100 mg/mL nasal solution |
| Cocaine 20% eye drops |
Cocaine (as cocaine hydrochloride) 200 mg/mL eye solution |
| Cocaine 4% conventional release eye drops |
Product containing precisely cocaine (as cocaine hydrochloride) 40 milligram/1 milliliter conventional release eye solution (clinical drug) |
| Cocaine 4% preservative-free eye drops |
Product containing precisely cocaine (as cocaine hydrochloride) 40 milligram/1 milliliter conventional release eye solution (clinical drug) |
| Cocaine 5% eye drops |
Product containing precisely cocaine (as cocaine hydrochloride) 50 milligram/1 milliliter conventional release eye solution (clinical drug) |
| Cocaine dependence with current use |
Cocaine dependence |
| Cocaine hydrochloride - non-pharmaceutical |
Cocaine hydrochloride |
| Cocaine hydrochloride 10% conventional release eye solution |
Product containing only cocaine in ocular dose form (medicinal product form) |
| Cocaine hydrochloride 10% single-use solution |
Product containing only cocaine in ocular dose form (medicinal product form) |
| Cocaine hydrochloride 10% topical solution |
Product containing only cocaine (medicinal product) |
| Cocaine hydrochloride 2.5% conventional release eye solution |
Product containing only cocaine in ocular dose form (medicinal product form) |
| Cocaine hydrochloride 2.5% single-use solution |
Product containing only cocaine in ocular dose form (medicinal product form) |
| Cocaine hydrochloride 4% topical solution |
Cocaine hydrochloride 40 mg/mL cutaneous solution |
| Cocaine viscous 10% conventional release cutaneous solution |
Product containing only cocaine (medicinal product) |
| Cocaine viscous 10% topical solution |
Product containing only cocaine (medicinal product) |
| Cocaine viscous 4% conventional release cutaneous solution |
Cocaine hydrochloride 40 mg/mL cutaneous solution |
| Cocaine viscous 4% topical solution |
Cocaine hydrochloride 40 mg/mL cutaneous solution |
| Cocaine+epinephrine 5%/0.02% eye drops |
Product containing precisely cocaine (as cocaine hydrochloride) 50 milligram/1 milliliter and epinephrine 200 microgram/1 milliliter conventional release eye solution (clinical drug) |
| Cocaine+homatropine 2%/2% eye drops |
Cocaine (as cocaine hydrochloride) 20 mg/mL and homatropine hydrobromide 20 mg/mL eye solution |
| Cochleo-orbicular reflex |
Auropalpebral reflex finding |
| Coconut - dietary |
Coconut (substance) |
| Cod - dietary |
Cod (substance) |
| Codeine phosphate + promethazine hydrochloride 10mg/6.25mg syrup |
Codeine phosphate 2 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution |
| Codeine phosphate+kaolin 10mg/3g/10mL mixture |
Product containing precisely codeine phosphate 1 milligram/1 milliliter and kaolin 300 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Coelenterate |
Phylum Cnidaria (organism) |
| Coenzyme-A transferase |
Coenzyme-A transferase |
| Cognitive impairment caused by ingestible alcohol |
Cognitive impairment caused by ethanol (disorder) |
| Coital sexual orgasm |
Coital sexual orgasm |
| environnement froid |
Cold environment |
| Colestyramine+aspartame 4g/sachet conventional release oral powder |
Product containing only colestyramine (medicinal product) |
| Colestyramine+aspartame 4g/sachet s/f oral powder |
Product containing only colestyramine (medicinal product) |
| Colestyramine+aspartame 4g/sachet s/f oral powder |
Product containing only colestyramine (medicinal product) |
| Colfosceril palmitate 108mg sterile powder for suspension |
Product containing precisely colfosceril palmitate 108 milligram/1 vial powder for conventional release suspension for endotracheopulmonary instillation (clinical drug) |
| Colistimethate sodium 1million international units powder for nebulization |
Colistimethate 40 mg/mL solution for inhalation |
| Colistin sulfate 1.5million units tablet |
Product containing precisely colistin 1.5 million unit/1 each conventional release oral tablet (clinical drug) |
| colitoxémie |
Sepsis |
| colitoxicosis |
Sepsis |
| Collagen punctal plug |
Collagen punctal plug (physical object) |
| préparation de collagénase |
Collagenase |
| Collection of 24-hour urine specimen for laboratory |
Urine specimen collection, 24 hours |
| Collection of specimen by nursing |
Specimen collection |
| Collier's stripes |
Collier's stripes (finding) |
| Coloboma of iris |
Congenital coloboma of iris |
| Colon flap |
Flap (substance) |
| Colon/rectum TNM finding |
American Joint Committee on Cancer allowable value |
| Colonic gland |
Colonic crypt of Lieberkühn |
| Colonna osteotomy for congenital deformity of hip |
Colonna arthroplasty (procedure) |
| Colonoscopy equivocal |
Colonoscopy equivocal (finding) |
| Colony-forming unit |
Stem cell colony-forming unit |
| Colony-forming unit, basophil |
Colony-forming unit of basophilic lineage (cell) |
| Colony-forming unit, blast |
Blast colony-forming unit (cell) |
| Colony-forming unit, diffusion chamber |
Diffusion chamber colony-forming unit (cell) |
| Colony-forming unit, eosinophil |
Colony-forming unit of eosinophilic lineage (cell) |
| Colony-forming unit, erythroid |
Colony-forming unit of erythroid lineage (cell) |
| Colony-forming unit, granulocyte |
Colony-forming unit of granulocytic lineage (cell) |
| Colony-forming unit, granulocyte-erythroid-macrophage-megakaryocyte |
Colony-forming unit of granulocytic-erythroid-macrophagocytic-megakaryocytic lineage (cell) |
| Colony-forming unit, granulocyte-macrophage |
Colony-forming unit of granulocytic-macrophagocytic lineage (cell) |
| Colony-forming unit, granulocyte-monocyte |
Colony-forming unit of granulocytic-monocytic lineage (cell) |
| Colony-forming unit, lymphoid-myeloid |
Colony-forming unit of lymphoid-myeloid lineage (cell) |
| Colony-forming unit, macrophage |
Colony-forming unit of macrophagocytic lineage (cell) |
| Colony-forming unit, megakaryocyte |
Colony-forming unit of megakarocytic lineage (cell) |
| Colony-forming unit, monocyte |
Colony-forming unit of monocytic lineage (cell) |
| Colony-forming unit, neutrophil-monocyte |
Colony-forming unit of neutrophilic-monocytic lineage (cell) |
| Colony-forming unit, spleen |
Spleen colony-forming unit (cell) |
| Colony-stimulating factor, megakaryocyte |
Thrombopoietin |
| Color symptom |
Finding of color of skin |
| Colorado tick fever virus subgroup |
Colorado tick fever virus |
| Colour symptom |
Finding of color of skin |
| Colubrid snake |
Family Colubridae - colubrid |
| Columba fasciata |
Patagioenas fasciata (organism) |
| Columnar cell papilloma uncertain whether benign or malignant |
Oncocytic Schneiderian papilloma of uncertain behavior (morphologic abnormality) |
| Comb-footed spider |
Family Theridiidae (organism) |
| Combined X-ray therapy |
X-ray beam therapy |
| Combined X-ray therapy |
X-ray beam therapy |
| Combined drug dependence, continuous |
Combined substance dependence, continuous |
| Combined drug dependence, excluding opioid, NOS |
Combined substance dependence, excluding opioids (disorder) |
| Combined drug dependence, excluding opioid, continuous |
Combined substance dependence, excluding opioid, continuous |
| Combined drug dependence, excluding opioid, episodic |
Combined substance dependence, excluding opioid, episodic |
| Combined drug dependence, excluding opioid, in remission |
Combined substance dependence, excluding opioid, in remission (disorder) |
| Combined drug dependence, excluding opioid, unspecified |
Combined substance dependence, excluding opioids (disorder) |
| dépendance à une association médicamenteuse, à l'exclusion des opiacés |
Combined substance dependence, excluding opioids (disorder) |
| Combined fast-electron therapy |
Fast-electron therapy |
| Combined fast-electron therapy |
Fast-electron therapy |
| Combined hamartoma of retina |
Combined hamartoma of retina and retinal pigment epithelium |
| Combined heavy particle therapy |
External beam radiation therapy particulate radiation (procedure) |
| Combined heavy particle therapy |
External beam radiation therapy particulate radiation (procedure) |
| Combined internal radiotherapy |
Radionuclide therapy |
| Combined internal radiotherapy |
Radionuclide therapy |
| Combined opioid with non-opioid drug dependence |
Combined opioid with non-opioid substance dependence |
| Combined opioid with non-opioid drug dependence in remission |
Combined opioid with non-opioid substance dependence in remission |
| Combined opioid with non-opioid drug dependence, continuous |
Combined opioid with non-opioid substance dependence, continuous (disorder) |
| Combined opioid with non-opioid drug dependence, episodic |
Combined opioid with non-opioid substance dependence, episodic |
| Combined opioid with other drug dependence NOS |
Combined opioid with non-opioid substance dependence |
| Combined opioid with other drug dependence, unspecified |
Combined opioid with non-opioid substance dependence |
| Combined photon therapy |
High-energy beam therapy |
| Combined photon therapy |
High-energy beam therapy |
FHIR